Vascular Embolization Market Report 2026

Vascular Embolization Market Overview

• Vascular Embolization market size has reached to $3.39 billion in 2025 • Expected to grow to $5.41 billion in 2030 at a compound annual growth rate (CAGR) of 9.9% • Growth Driver: Vascular Embolization Market Gains Traction Amidst Rising Chronic Kidney Diseases • Market Trend: Breakthrough In Vascular Embolization For Precise And Controlled Target Vessel Occlusion • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Vascular Embolization Market?

Vascular embolization is a minimally invasive procedure that uses different materials, such as coils, particles, or liquid agents, to block or impede blood vessels to halt arterial bleeding. It blocks blood vessels for various purposes, such as treating malignancies, shrinking vascular abnormalities, or re-directing flow. The main products of vascular embolization are embolic agents and embolization devices. Embolic agents are chemicals or materials that are injected or put in specified regions to block or occlude blood vessels and successfully cure a variety of medical problems. These are used in various operations to treat a variety of medical diseases such as tumors, aneurysms, and arteriovenous malformations (AVMs). The various embolization techniques are coiling devices and non-coiling devices that are used in various applications such as peripheral vascular diseases, oncology, urology, neurology, and others, and also by various end users such as hospitals, specialty clinics, ambulatory surgical centers, and diagnostic centers.

What Is The Vascular Embolization Market Growth Forecast?

The vascular embolization market size is expected to see strong growth in the next few years. It will grow to $5.41 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing demand for targeted therapies, rising investments in interventional oncology, expansion of outpatient embolization procedures, growing adoption of advanced imaging integration, increasing focus on patient-centric treatment options. Major trends in the forecast period include increasing adoption of minimally invasive embolization procedures, rising use of advanced embolic materials, growing demand for image-guided interventions, expansion of oncology-related embolization applications, enhanced focus on procedure precision and safety.

Global Vascular Embolization Market Segmentation

1) By Product: Embolic Agents, Embolization Devices 2) By Embolization Technique: Coiling Devices, Non-Coiling Devices 3) By Application: Peripheral Vascular Diseases, Oncology, Urology, Neurology, Other Applications 4) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers Subsegments: 1) By Embolic Agents: Particle Embolic Agents, Liquid Embolic Agents, Coil Embolic Agents, Gelatin Sponge Embolic Agents 2) By Embolization Devices: Balloon Occlusion Devices, Catheters, Thrombin Injection Systems

What Is The Driver Of The Vascular Embolization Market?

High prevalence of chronic kidney diseases is expected to propel the growth of the vascular embolization market going forward. Chronic Kidney Disease (CKD) refers to a condition in which the kidneys are gradually and irreversibly damaged over time. The use of vascular embolization in chronic kidney disease (CKD) can be used to stop bleeding from kidney tumors, arteriovenous malformations (AVMs), or complications of kidney biopsies or transplants and avoids open surgery and its associated risks, particularly in patients with compromised kidney function. For instance, in June 2023, according to ZS Associates, a UK-based Kidney Research Commission, the prevalence of kidney disease in the UK is estimated to affect 7.19 million people in 2023, more than 10% of the population, and is expected to rise to 7.61 million by 2033, with the proportion of patients in later stages of the disease increasing from 45% to 51%. Therefore, the high prevalence of chronic kidney diseases is driving the growth of the vascular embolization industry.

Key Players In The Global Vascular Embolization Market

Major companies operating in the vascular embolization market are Abbott Laboratories, Medtronic Plc., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Kaneka Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Teleflex Inc., Cook Group Incorporated, Merit Medical Systems Inc., Penumbra Inc., MicroPort Scientific Corporation, MicroVention Inc., Medikit Co Ltd., Silk Road Medical Inc., Galt Medical Corporation, Neuravi Ltd., Phenox GmbH, Spartan Micro Inc., EndoShape Inc., Shape Memory Medical Inc., Balt Group, Vascular Solutions Inc.

Global Vascular Embolization Market Trends and Insights

Major companies operating in the vascular embolization market are innovating new products such as embolic systems to increase their profitability in the market. An embolic system refers to the combination of embolic agents and delivery devices used to intentionally block blood vessels. Vascular embolization is a medical procedure in which these embolic systems are employed to occlude or reduce blood flow to specific areas of the body. For instance, in October 2023, Sirtex Medical, a US-based medical device company launched Lava liquid embolic system (LES). Lava, with its 2-mL and 6-mL volume options, offers a versatile solution for controlled target vessel occlusion in peripheral vasculature. Its varied viscosity options enable effective distal embolization of small, hard-to-reach vessels. The FDA approved the Lava LES based on its safety and efficacy demonstrated in the single-arm LAVA Study, a prospective, multicenter trial evaluating acute peripheral arterial hemorrhages.

What Are Latest Mergers And Acquisitions In The Vascular Embolization Market?

In May 2023, Stryker Corporation, a US-based medical technology company, acquired Cerus Endovascular Ltd. for an undisclosed amount. Through this acquisition, Stryker aims to expand its neurovascular and embolization portfolio by integrating Cerus Endovascular’s CE-marked contour neurovascular system and neqstent coil assisted flow diverter, which are designed for minimally invasive intrasaccular treatment of intracranial aneurysms. Cerus Endovascular Ltd. is a UK-based commercial-stage medical device company specializing in innovative endovascular solutions for aneurysm therapy.

Regional Outlook

North America was the largest region in the vascular embolization market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Vascular Embolization Market?

The vascular embolization market consists of revenues earned by entities by providing vascular embolization techniques such as chemoembolization or radioembolization, sac packing, sandwich technique, stent-assisted coiling, and particle embolization. The market value includes the value of related goods sold by the service provider or included within the service offering. The vascular embolization market also includes sales of balloons, gelatin foam, liquid glue, liquid sclerosing agents, particulate agents, detachable coils, and push able coils. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vascular Embolization Market Report 2026?

The vascular embolization market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vascular embolization industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.